tradingkey.logo

Bio Rad Laboratories Inc

BIOb
309.655USD
+7.315+2.42%
收盤 02/09, 16:00美東報價延遲15分鐘
8.75B總市值
虧損本益比TTM

Bio Rad Laboratories Inc

309.655
+7.315+2.42%

關於 Bio Rad Laboratories Inc 公司

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Bio Rad Laboratories Inc簡介

公司代碼BIOb
公司名稱Bio Rad Laboratories Inc
上市日期Mar 17, 1980
CEOSchwartz (Norman D)
員工數量7700
證券類型Ordinary Share
年結日Mar 17
公司地址1000 Alfred Nobel Dr
城市HERCULES
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編94547
電話15107247000
網址https://www.bio-rad.com/
公司代碼BIOb
上市日期Mar 17, 1980
CEOSchwartz (Norman D)

Bio Rad Laboratories Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
431.47K
+57000.00%
Mr. James J. Barry
Mr. James J. Barry
Executive Vice President, President - Life Science Group
Executive Vice President, President - Life Science Group
--
--
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
--
--
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
--
--
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
--
--
Rajat Mehta
Rajat Mehta
Executive Vice President - Global Commercial Operations
Executive Vice President - Global Commercial Operations
--
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
--
--
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
431.47K
+57000.00%
Mr. James J. Barry
Mr. James J. Barry
Executive Vice President, President - Life Science Group
Executive Vice President, President - Life Science Group
--
--
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
--
--
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
--
--
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
--
--
Rajat Mehta
Rajat Mehta
Executive Vice President - Global Commercial Operations
Executive Vice President - Global Commercial Operations
--
--

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
270.00M
41.35%
EMEA
222.20M
34.03%
APAC
121.00M
18.53%
Other
39.80M
6.09%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 4月2日 週三
更新時間: 4月2日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Blue Raven Partners, L.P.
80.10%
Alice N. Schwartz Revocable Trust
8.63%
Schwartz (Norman D)
8.51%
Schwartz (Steven D)
0.75%
Allison (Schwartz)
0.08%
其他
1.92%
持股股東
持股股東
佔比
Blue Raven Partners, L.P.
80.10%
Alice N. Schwartz Revocable Trust
8.63%
Schwartz (Norman D)
8.51%
Schwartz (Steven D)
0.75%
Allison (Schwartz)
0.08%
其他
1.92%
股東類型
持股股東
佔比
Corporation
88.74%
Individual Investor
9.35%
Investment Advisor
0.07%
其他
1.85%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
13
3.81K
0.08%
+600.00
2025Q3
15
3.80K
0.10%
+757.00
2025Q2
15
3.05K
0.12%
+2.00
2025Q1
18
3.04K
0.13%
-3.56K
2024Q4
18
4.22K
0.13%
-23.00
2024Q3
17
4.24K
0.12%
+647.00
2024Q2
18
3.60K
0.13%
-211.00
2024Q1
19
3.81K
0.15%
-3.64K
2023Q4
20
3.78K
2.06%
-1.99K
2023Q3
20
5.76K
2.06%
+2.00
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Blue Raven Partners, L.P.
4.06M
80.1%
--
--
Sep 25, 2025
Alice N. Schwartz Revocable Trust
437.51K
8.63%
--
--
Sep 25, 2025
Schwartz (Norman D)
431.47K
8.51%
+57.00K
+15.22%
Sep 25, 2025
Schwartz (Steven D)
38.24K
0.75%
--
--
Sep 25, 2025
Allison (Schwartz)
4.00K
0.08%
+57.00
+1.45%
Feb 24, 2025
CSS, LLC
1.09K
0.02%
--
--
Sep 30, 2025
Focus Partners Wealth, LLC
760.00
0.01%
+760.00
--
Sep 30, 2025
Buckingham Strategic Wealth, LLC
760.00
0.01%
--
--
Jun 30, 2024
Morgan Stanley Smith Barney LLC
692.00
0.01%
--
--
Sep 30, 2025
Wells Fargo Advisors
170.00
0%
--
--
Sep 30, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI